China Hyaluronidase Market Is Expected to Reach USD 176.6 Million By 2030

The China hyaluronidase market was valued at USD 44.8 Million in 2022 and is expected to reach USD 176.6 Million by 2030, growing at a CAGR of 18.56% during the forecast period.

Hyaluronidase is an enzyme that is used in various medical and cosmetic procedures. It works by breaking down hyaluronic acid, a substance that is naturally present in the body and plays a role in maintaining skin hydration and tissue structure. In medical settings, hyaluronidase is used to improve the absorption and distribution of drugs, as well as to treat conditions such as edema and cysts.

In cosmetic procedures, hyaluronidase is used to dissolve dermal fillers and correct overfilling or unwanted results. This makes it a valuable tool for non-invasive cosmetic procedures, as it can quickly and safely reverse the effects of dermal fillers without requiring surgery. While hyaluronidase has shown to be effective in these applications, there are potential risks and side effects, and its use should be carefully evaluated and monitored by healthcare professionals.

The China hyaluronidase market is driven by the growing demand for non-invasive cosmetic procedures and increasing awareness about the enzyme's benefits for aesthetic treatments. Additionally, the rising prevalence of skin disorders and chronic diseases such as cancer are creating opportunities for the use of hyaluronidase in medical settings. However, the market faces challenges such as the lack of standardized regulations and the high cost of the enzyme. The presence of alternative treatments and potential side effects also pose restraints to China hyaluronidase industry growth.

The ongoing COVID-19 pandemic has also affected the healthcare industry in China, causing delays and decreased demand for hyaluronidase procedures. In order to overcome these challenges and take advantage of opportunities, companies in the market must focus on research and development, cost-effectiveness, and patient safety.

The China hyaluronidase market is segmented based on type, application, and region

Based on type, the market is bifurcated into animal-derived hyaluronidase and synthetic hyaluronidase. The animal-derived hyaluronidase segment held the largest market share in 2022 and is further projected to grow exponentially during the forecast period. The animal-derived hyaluronidase segment of the market has been growing steadily in recent years. This is due to the established use of animal-derived hyaluronidase in medical settings and its efficacy in treating a range of conditions. In addition, animal-derived hyaluronidase has a longer shelf life and is more stable than synthetic hyaluronidase, which makes it a preferred choice for certain applications.

The growing demand for aesthetic treatments has also contributed to the growth of the animal-derived hyaluronidase market, as it is used to dissolve dermal fillers. Furthermore, the increasing prevalence of chronic diseases such as cancer and the need for rapid drug delivery has created new opportunities for the use of animal-derived hyaluronidase. With ongoing research and development, this segment of the market is expected to continue to grow in the future.

Based on application, the market is segmented into chemotherapy, dermatology, ophthalmology, plastic surgery, and others. The Dermatology segment held the largest market share in 2022 and is further projected to grow exponentially during the forecast period. The dermatology segment of the China hyaluronidase market has been experiencing significant growth in recent years. This is due to the increasing demand for aesthetic treatments and the use of hyaluronidase to dissolve dermal fillers. Hyaluronidase is used to reverse the effects of hyaluronic acid-based fillers and to treat complications such as overfilling, nodules, and bumps.

The procedure is minimally invasive and provides immediate results, making it a popular choice for patients. Furthermore, the high prevalence of skin conditions such as acne, eczema, and psoriasis has also contributed to the growth of this segment of the market. With ongoing technological advancements and increasing awareness about the benefits of hyaluronidase, the dermatology segment of the China hyaluronidase market is expected to continue to grow in the future.

Browse the full “China Hyaluronidase Market By Type (Animal-Derived Hyaluronidase, Synthetic Hyaluronidase), By Application (Chemotherapy, Dermatology, Ophthalmology, Plastic Surgery, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2023 – 2030.” Report at https://www.zionmarketresearch.com/report/china-hyaluronidase-market

Recent Developments

• In 2019, Bloomage Biotechnology announced that it had signed a strategic collaboration agreement with Haohai Biological Technology to jointly develop and commercialize hyaluronic acid and hyaluronidase products for the Chinese market. The collaboration aims to leverage the expertise and resources of both companies to bring innovative solutions to the market.
• In 2021, Shandong Freda Biotechnology launched a new hyaluronidase product, which is derived from Streptococcus zooepidemicus. The product is marketed as a sterile freeze-dried powder for injection and is indicated for the treatment of hyaluronic acid-based filler complications and the improvement of skin elasticity and moisture.

The China hyaluronidase market is dominated by players such as:

• Bloomage BioTechnology Corporation Limited
• Q-Med AB
• IBSA Farmaceutici Italia Srl
• Guangdong Techpool Bio-Pharma Co. Ltd.
• Shandong Runxin Biotechnology Co. Ltd.
• China Resources Double-Crane Pharmaceutical Co. Ltd.
• Jiangsu Wanbang Biopharmaceuticals Co. Ltd.
• Lanzhou Institute of Biological Products Co. Ltd.
• Shanghai Sunflower Group Co. Ltd.
• Hangzhou Huadong Medicine Group Sanxing Pharmaceutical Co. Ltd.
• LifeTech Scientific Corporation
• Shanghai Jingfeng Pharmaceutical Co. Ltd.
• Sichuan Kelun Pharmaceutical Co. Ltd.
• Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
• Changzhou Institute of Pharmaceutical Research Co. Ltd.
• Henan Lingrui Pharmaceutical Co. Ltd.
• Shenzhen Techdow Pharmaceutical Co. Ltd.
• Wuhan Wuyao Pharmaceutical Co. Ltd.
• Zhejiang Haizheng Pharmaceuticals Co. Ltd.
• Tonghua Dongbao Pharmaceutical Co. Ltd.

The China hyaluronidase market report is segmented as follows:

By Type

• Animal-Derived Hyaluronidase
• Synthetic Hyaluronidase

By Application

• Chemotherapy
• Dermatology
• Ophthalmology
• Plastic Surgery
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com